Works matching IS 00221899 AND DT 2023 AND VI 227 AND IP 1

Results: 22
    1
    2

    Intranasal M2SR (M2-deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies In Adults.

    Published in:
    Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 103, doi. 10.1093/infdis/jiac433
    By:
    • Eiden, Joseph;
    • Fierro, Carlos;
    • Schwartz, Howard;
    • Adams, Mark;
    • Ellis, Kimberly J;
    • Aitchison, Roger;
    • Herber, Renee;
    • Hatta, Yasuko;
    • Marshall, David;
    • Moser, Michael J;
    • Belshe, Robert;
    • Greenberg, Harry;
    • Coelingh, Kathleen;
    • Kawaoka, Yoshihiro;
    • Neumann, Gabriele;
    • Bilsel, Pamuk
    Publication type:
    Article
    3
    4

    Reply to de Silva and White.

    Published in:
    Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 165, doi. 10.1093/infdis/jiac425
    By:
    • DeMaso, Christina;
    • Sharma, Mayuri
    Publication type:
    Article
    5
    6

    Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months.

    Published in:
    Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 71, doi. 10.1093/infdis/jiac407
    By:
    • Stuart, Arabella S V;
    • Virta, Miia;
    • Williams, Kristi;
    • Seppa, Ilkka;
    • Hartvickson, Robyn;
    • Greenland, Melanie;
    • Omoruyi, Edmund;
    • Bastian, Arangassery Rosemary;
    • Haazen, Wouter;
    • Salisch, Nadine;
    • Gymnopoulou, Efi;
    • Callendret, Benoit;
    • Faust, Saul N;
    • Snape, Matthew D;
    • Heijnen, Esther
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice.

    Published in:
    Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 50, doi. 10.1093/infdis/jiac382
    By:
    • Roe, Molly K;
    • Perez, Maria A;
    • Hsiao, Hui-Mien;
    • Lapp, Stacey A;
    • Sun, He-Ying;
    • Jadhao, Samadhan;
    • Young, Audrey R;
    • Batista, Yara S;
    • Reed, Ryan C;
    • Taz, Azmain;
    • Piantadosi, Anne;
    • Chen, Xuemin;
    • Liang, Bo;
    • Koval, Michael;
    • Snider, Timothy A;
    • Moore, Martin L;
    • Anderson, Evan J;
    • Anderson, Larry J;
    • Stobart, Christopher C;
    • Rostad, Christina A
    Publication type:
    Article
    15
    16

    Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways.

    Published in:
    Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 123, doi. 10.1093/infdis/jiac375
    By:
    • Hall, Samuel A L;
    • Burns, Gareth S;
    • Mooney, Benjamin J;
    • Millen, Rosemary;
    • Morris, Rachel;
    • Vogrin, Sara;
    • Sundararajan, Vijaya;
    • Ratnam, Dilip;
    • Levy, Miriam T;
    • Lubel, John S;
    • Nicoll, Amanda J;
    • Strasser, Simone I;
    • Sievert, William;
    • Desmond, Paul V;
    • Ngu, Meng C;
    • Angus, Peter;
    • Sinclair, Marie;
    • Meredith, Christopher;
    • Matthews, Gail;
    • Revill, Peter A
    Publication type:
    Article
    17
    18
    19
    20
    21

    Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.

    Published in:
    Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 23, doi. 10.1093/infdis/jiac320
    By:
    • Somersan-Karakaya, Selin;
    • Mylonakis, Eleftherios;
    • Menon, Vidya P;
    • Wells, Jason C;
    • Ali, Shazia;
    • Sivapalasingam, Sumathi;
    • Sun, Yiping;
    • Bhore, Rafia;
    • Mei, Jingning;
    • Miller, Jutta;
    • Cupelli, Lisa;
    • Forleo-Neto, Eduardo;
    • Hooper, Andrea T;
    • Hamilton, Jennifer D;
    • Pan, Cynthia;
    • Pham, Viet;
    • Zhao, Yuming;
    • Hosain, Romana;
    • Mahmood, Adnan;
    • Davis, John D
    Publication type:
    Article
    22